Department of Neurology Home >
- Faculty
Dennis L. Kolson
Associate Professor of Neurology
Department: Neurology
Contact information
280C Clinical Research Building
University of Pennsylvania
415 Curie Blvd.
Philadelphia, PA 19104/6146
University of Pennsylvania
415 Curie Blvd.
Philadelphia, PA 19104/6146
Office: 215 573-3505
Fax: 215 573-2029
Fax: 215 573-2029
Email:
KOLSOND@MAIL.MED.UPENN.EDU
KOLSOND@MAIL.MED.UPENN.EDU
Graduate Group Affiliations
Publications
Education
B.S. (Biology)
Pennsylvania State University, magna cum laude, 1978.
M.S. (Biological Sciences)
University of Pittsburg, 1980.
Ph.D. (Biological Sciences)
University of Pittsburgh, 1984.
M.D.
University of Pittsburgh School of Medicine, cum laude, 1985.
B.S. (Biology)
Pennsylvania State University, magna cum laude, 1978.
M.S. (Biological Sciences)
University of Pittsburg, 1980.
Ph.D. (Biological Sciences)
University of Pittsburgh, 1984.
M.D.
University of Pittsburgh School of Medicine, cum laude, 1985.
Post-Graduate Training
Intern In Medicine, Mercy Hospital of Pittsburgh, Pittsburgh, 1985-1986.
Resident in Neurology, Duke Univ. Medical Center, Durham, North Carolina, 1986-1989.
Fellow in Neurovirology, Univ. of Penn., Philadelphia, PA, 1989-1992.
Intern In Medicine, Mercy Hospital of Pittsburgh, Pittsburgh, 1985-1986.
Resident in Neurology, Duke Univ. Medical Center, Durham, North Carolina, 1986-1989.
Fellow in Neurovirology, Univ. of Penn., Philadelphia, PA, 1989-1992.
Certifications
Amercian Board of Neurology and Psychiatry, 1990.
Permanent linkAmercian Board of Neurology and Psychiatry, 1990.
Description of Research Expertise
Research InterestsMechansims and determinants of HIV induced neuronal injury. Neuronal cell responses to virus induced injury.
Key words: neuron, hippocampus, apoptosis, gene expression, single-cell mRNA, HIV, chemokine receptor, NMDA receptor.
Description of Research
My laboratory is focused upon pathogenesis of HIV-1-infection of the central nervous system (CNS). We utilize techniques of single-cell microdissection and mRNA expression analysis, and standard molecular biological approaches in our unique in vitro model to study mechanisms of neurodegeneration caused by HIV. Within the CNS, HIV productively infects macrophages and microglia, with subsequent neuronal loss by apoptosis. In vitro modeling shows that such infection results in the release of soluble neurotoxins that act in part through activation of neuronal NMDA receptors with subsequent activation of cell death pathways, including apoptosis cascades and calpain activation. Specific NMDA receptor subunits (NR2A, NR2B) are critical for such degeneration. In addition, dysregulation of glial (astrocyte, macrophage) neurotransmitter and oxidative functions may subserve both apoptotic and anti-apoptotic roles. Major unanswered questions include:
1. What pathways are reponsible for neuronal apoptosis/damage and glial cell dysfunction in HIV infection?
2. How can NMDA receptor modulation alter neuronal susceptibility to HIV-induced damage?
3. Are specific genes turned on/off in neurons that are particularly vulnerable/resistant to HIV-induced injury?
4. What is the role of endogenous neuronal survival pathways in preventing HIV-induced damage?
5. How can in vitro modeling be used to define targets for neuroprotection against HIV-1?
6. How can single-cell mRNA analysis be used to define patterns of gene expression in the brain to define mechanisms of neuronal death/damage and survival that may identify unique targets for neuroprotective strategies against HIV?
To address these questions, we have developed several in vitro neuronal cell culture systems. We utilize primary rodent hippocampal and neocortical cell cultures as well as a unique human neuronal cell system utilizing NT2.N neurons in mixed neuronal/glial cell cultures to model HIV-1-induced neurodegeneration. We have developed a novel in vitro model using mixed cultures of human monocyte-derived macrophages with rodent neurons and astrocytes to analyze effects of HIV infection in the central nervous system. We have found that developmental susceptibility to HIV-1-induced neurodegeneration is determined by NMDA receptor subunit expression, and that the macrophage kynurenine metabolic pathway is a major contributor to the production of HIV-1-induced excitotoxin expression. We have utilized single-cell microdissection and mRNA expression analyses to develop gene expression profiles in individual neurons in archival human brain and in cell cultures. Our current projects involve in vitro and in vivo analysis of cell death pathways in neurons that are induced by HIV-infected macrophages, analysis of the role of specific NMDA receptor subunits in determining neuronal vulnerability to HIV-induced damage, analysis of the modulation of the kynurenine metabolic pathway in macrophages by HIV-1, and in vitro analysis of neuronal gene expression in hippocampal and neocortical cell cultures through single-cell mRNA analysis.
Rotation Projects for 2006-2007
1. Analysis of NMDA receptor subunit expression and phosphorylation patterns in hippocampal and cortical neurons susceptible to HIV neurotoxicity
2. Analysis of neuronal gene expression,in HIV-injured hippocampal and neocortical cells utilizing single-cell microdissection and mRNA analysis.
3. Identification of the downstream pathways of death in neurons by HIV-1, including the role of calpain activation.
Lab personnel:
Praveena Sabnekar, PhD - Research Specialist
Lorraine Kolson, BS - Research Specialist
Rebecca Chodroff, BS - Research Specialist
Lauren O'Donnell - CAMB Graduate student
Stephan Kadauke – CAMB MD/PhD student
Selected Publications
Kolson DL, Sabnekar P, Baybis M and Crino PB: Gene expression in TUNEL-positive Neurons in HIV-infected brain. J. Neurovirol. 10((suppl. 1)): 102-7, 2004.Patel SH, Kolson DL, Glosser G, Matozzo I, Ge Y, Babb JS, Mannon LJ and Grossman RI. : Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV infected patients. Am. J. Neuroradiol. 23: 543-549, 2002.
Chen W, Sulcove J, Frank I, Jaffer S, Ozdener H and Kolson DL. : Development of a human neuronal cell model for HIV/macrophage-induced neurotoxicity: apoptosis induced by HIV-1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway. J. Virology 76: 9407-9419, 2002.
Ge Y, Grossman RI, Babb JS, Rabin ML, Mannon LJ and Kolson DL. : Age-related total gray matter and white matter changes in normal adult brain. Part I. Volumetric MR imaging analysis. Am. J. Neuroradiol. 23: 1327-1333, 2002.
Ge Y, Grossman RI, Babb JS, Rabin ML, Mannon LJ and Kolson DL. : Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis. Am. J. Neuroradiol. 23: 1334-1341, 2002.
O’Donnell, LA, Chen W, Agrawal A, Sulcove J and Kolson DL. : Potential neuroprotective role of APJ/apelin interactions: protection against HIV-induced apoptosis. NIMH workshop: Viral and Host Genetic Factyors Regulating HIV/CNS Disease, Rockville, MD. 2002.
Martin-Garcia J, Kolson DL, Gonzalez-Scarano F. : Chemokine receptors in the brain: their role in HIV infection and pathogenesis. AIDS (in press). 2002.
Kolson DL. : Neuropathogenesis of central nervous system HIV-1 infection. Clin. Lab. Med. 22: 1-15, 2002.
Ge Y, Grossman RL, Udupa JK, Babb JS, Kolson DL and McGowan JC. : Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. Am. J. Neuroradiol. 22: 470-475, 2001.
Ge Y, Grossman RL, Udupa JK, Babb JS, Nyul LG and Kolson DL. : Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 220: 606-610, 2001.

